Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02CTS
|
||||
| Former ID |
DCL001219
|
||||
| Drug Name |
Ospemifene
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
Shionogi; QuatRx
|
||||
| Formula |
C24H23ClO2
|
||||
| InChI |
InChI=1S/C24H23ClO2/c25-16-15-23(19-7-3-1-4-8-19)24(20-9-5-2-6-10-20)21-11-13-22(14-12-21)27-18-17-26/h1-14,26H,15-18H2/b24-23-
|
||||
| InChIKey |
LUMKNAVTFCDUIE-VHXPQNKSSA-N
|
||||
| CAS Number |
CAS 128607-22-7
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| SuperDrug ATC ID |
G03XC05
|
||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Modulator | [551684] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
| Ref 532651 | 2013 FDA drug approvals. Nat Rev Drug Discov. 2014 Feb;13(2):85-9. | ||||
| Ref 542369 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7349). | ||||
| Ref 551684 | Clinical pipeline report, company report or official report of Shionogi (2011). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.